Government Lawsuit Alleges HIV Drug Maker Gilead Profited Illegally From Taxpayer Research
A Justice Department lawsuit accuses Gilead of patent infringement in its sale of Truvada and Descovy as HIV prevention drugs.…
«
»
A Justice Department lawsuit accuses Gilead of patent infringement in its sale of Truvada and Descovy as HIV prevention drugs.…
An HIV drug lawsuit removed to federal court last week blames the side effects of Atripla and Viread for kidney and bone damage, saying Gilead sat on a safer alternative while failing to warn doctors or patients about the risks.…
Lawsuits allege that side effects of Truvada, Viread, Atripla, Complera and Stribild may have been avoided if the manufacturer had not withheld safer versions of the HIV drugs as part of a scheme to maximize profits.…
A lawsuit filed against Gilead by 41 plaintiffs say it intentionally held back a safer HIV drug to make more profit, resulting in them suffering bone and kidney injuries.…
The FDA has approved a new HIV drug, Descovy, for use as a prophylactic to prevent the spread of HIV.…
A new study finds little risk of bone fractures from Truvada for PrEP use, indicating only those at high risk of fractures already should be concerned.…
A Truvada lawsuit claims Gilead failed to warn patients that the drug could cause the death of bone tissue due to is high toxicity.…
A CDC study found that use of Truvada for HIV prevention increased 500% from 2014 to 2017.…
U.S. lawmakers are wondering whether Gilead’s recent donation of millions of bottles of Truvada came with a backdoor deal for the government to drop patent claims on the drug.…
A new class action lawsuit by an investor group accuses Gilead and other drug makers of antitrust law violations for preventing generic versions of HIV drugs.…